Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultralow Dose PET Imaging for Detecting 18F-NaF Uptake
NCT07284563Phase 2Recruiting
- Sponsor
- Akiva Mintz
- Start
- Sep 2025
- Primary completion
- Jun 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium fluoride f-18 in bone disease, bone cancer, malignant neoplasm of bone and articular cartilage, osteomyelitis (OM), septic arthritis, sponsored by Akiva Mintz. Started Sep 2025; status: recruiting.
02
Drugs
sodium fluoride f-18
03
Conditions
bone diseasebone cancermalignant neoplasm of bone and articular cartilageosteomyelitis (OM)septic arthritis
Beyond the preview
Go deeper on NCT07284563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07284563.